The cost of certain procedures or treatments can be quite large and controlling these costs has bedeviled the health system for a long time. The public programs, Medicare and Medicaid, can deal with this issue to some extent by fiat–just saying we will only pay a set amount, which is limited only by political pressure that providers and suppliers may be able to exert. A new method being tried by commercial payers is to set a price that they will pay for the procedure or treatment and see which providers will accept that. A report from the Center for Studying Health System Change examines early experience with the method and identifies challenges in how it might be adopted by other payers. (CSHSC Report) The index case for reference pricing is CalPERS use of the technique in regard to hip and knee replacements. CalPERS invented enrollees to use hospitals for these procedures that would charge at or below a set price, and engaged in an extensive education effort to encourage use of these hospitals. Data showed prices from $15,000 to $110,000 for these procedures, with no distinguishable difference in quality. CalPERS decided to set the reference price at $30,000. Early results suggest that a number of procedures were moved to these facilities and many hospitals found it necessary to lower their prices to the reference price in order to keep business. There was no deterioration in quality and enrollees saved money. Some of the challenges for payers to utilize reference pricing is difficulty in getting enough cost and price information to set an appropriate reference price, fear of disrupting existing hospital relationships, and fear of upsetting enrollees who may have difficulty understanding the program. In addition, the total cost savings possible are limited because a relatively small number of procedures are likely to be amenable to reference pricing. And the technique only addresses unit cost, not the appropriateness of utilization. Nonetheless, every little bit of savings helps and anything that offsets the increasing market power of hospitals is very welcome.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
Reciprocal Trade Barriers
February 13, 2025
Reciprocal Trade Barriers
Trump's imposition of reciprocal tariffs is briliant, exposing the hypocrisy of other countries that have…
Commentary
We Are Truly F**ked
February 12, 2025
We Are Truly F**ked
A bad inflation report, a bad deficit report, a bad ten-year US note auction; Trump…
Commentary
Private Equity Ownership and Health Care Prices
February 12, 2025
Private Equity Ownership and Health Care Prices
Financial investor ownership of health care providers results in higher prices.